Bristol-Myers Squibb founds molecular synthesis centre with Princeton University

Bristol-Myers Squibb has announced a research collaboration with Princeton University, which will involve the establishment of a new centre for molecular synthesis.

This will create opportunities for scientists from the two organisations to collaborate on synthetic chemistry research, allowing for a robust exchange of scientific ideas.

Research projects will focus on areas of mutual interest and benefit, taking advantage of the expertise developed in the laboratories of the Princeton faculty to conduct cutting-edge science within the pharmaceutical industry.

The centre will also fund a select group of research fellows each year for the next half-decade. Each research fellow will be paired with a Bristol-Myers Squibb mentor who will provide scientific guidance and industrial chemistry expertise.

Dr Percy Carter, head of discovery chemistry at Bristol-Myers Squibb, said: "Bristol-Myers Squibb has a long history of engaging in external collaborations and partnerships of all shapes and sizes, always with an eye toward advancing science."

The company also announced the completion of its acquisition of Cardioxyl Pharmaceuticals this week.